Back to Screener

Healthcare

Oscar Health, Inc.(OSCR)

Live Price

Offline

$28.40

+0.46% today

1Y Change

+38.67%

Window

Jun 26, 2025 โ†’ Jun 18, 2026

Market Cap
$4.79B
Revenue Growth
+27.5%
EPS Growth
-1636.4%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Oscar Health, Inc. (OSCR) is a Healthcare stock with a market cap of $4.79B and listed on NYSE. The stock last traded around $28.40 and up 38.7% across the available one-year price window (Jun 26, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +27.5%, EPS growth of -1636.4%, a dividend yield of 0.0%. What stands out right now is revenue +27.5%, EPS -1636.4%, free cash flow +11.4% with operating margin -3.4% and ROIC -27.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines OSCR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+27.5% vs +7.6% peer median

Operating Margin

Below sector median

-3.4% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 6, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at +27.5% and EPS is at -1636.4%, with operating margin around -3.4%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged +3.2% over the next 5 trading days and finished higher after 2 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 6, 2026
โ€”+5.2%+19.1%+19.0%
2026
Feb 10, 2026
-34.6%+5.6%+6.4%+4.0%
2025
Nov 6, 2025
+3.6%+7.0%-15.8%+1.3%

Benchmark Edge

OSCR vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

OSCR

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

OSCR Max Drawdown

-51.71%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for OSCR and SPY.

Calendar-year return history is still loading or unavailable.
Oscar Health, Inc. logo

Company Overview

Oscar Health, Inc.

New York Stock Exchange

New York City, NY, US

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Leadership
Mark Thomas Bertolini
IPO Date
Mar 3, 2021
Employees
2.4k
Street Address
75 Varick Street
Mailing
New York City, NY, 10013
Region
New York City, NY, US
Reporting Currency
USD
Investor Line
(646) 403-3677
Last Updated
May 3, 2026
CIK: 0001568651ISIN: US6877931096CUSIP: 687793109
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
0.4
Price/Book
5.4

Growth

Revenue
+27.5%
EPS
-1636.4%
Free Cash Flow
+11.4%

Profitability

Gross Margin
14.4%
Operating Margin
-3.4%
Net Margin
-3.8%
ROE
-39.5%
ROIC
-27.1%

Balance Sheet

Debt/Equity
0.44
Current Ratio
0.95

Earnings Reports

๐Ÿ“… Last reportedMay 6, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 6, 26
โ€”
Est 1.21
โ€”
โ€”
Est 4907488.0B
โ€”
โ€”
Feb 10, 26
โœ—
-1.24
Est -0.92
-34.6%
2746660.0B
Est 3123365.0B
-12.1%
โ€”
Nov 6, 25
โœ“
-0.53
Est -0.55
+3.6%
2985984.0B
Est 3052441.6B
-2.2%
โ€”
Aug 6, 25
โœ“
-0.89
Est -0.90
+1.1%
2863945.0B
Est 3073302.8B
-6.8%
โ€”
May 7, 25
โœ“
0.92
Est 0.83
+10.8%
3046263.0B
Est 2778306.6B
+9.6%
โ€”
Feb 4, 25
โœ—
-0.62
Est -0.55
-12.7%
2392436.0B
Est 2825881.4B
-15.3%
โ€”
Nov 7, 24
โœ—
-0.22
Est -0.20
-10.0%
2423482.0B
Est 2339220.0B
+3.6%
โ€”
Aug 7, 24
โœ“
0.20
Est 0.16
+25.0%
2219341.0B
Est 2154640.0B
+3.0%
โ€”
May 7, 24
โœ“
0.62
Est 0.27
+129.6%
2142305.0B
Est 2154640.0B
-0.6%
โ€”
Feb 7, 24
โœ“
-0.66
Est -0.74
+10.8%
1431658.0B
Est 1420180.0B
+0.8%
โ€”
Nov 7, 23
โœ“
-0.29
Est -0.47
+38.3%
1439961.0B
Est 1423430.0B
+1.2%
โ€”
Aug 8, 23
โœ“
-0.07
Est -0.33
+78.8%
1522124.0B
Est 1439500.0B
+5.7%
โ€”
May 9, 23
โœ—
-0.18
Est -0.05
-254.7%
1469685.0B
Est 1146110.0B
+28.2%
โ€”
Feb 9, 23
โœ—
-1.05
Est -1.01
-4.0%
1037660.0B
Est 1175493.6B
-11.7%
โ€”
Nov 8, 22
โœ—
-0.91
Est -0.76
-19.7%
40086.0B
Est 1068260.9B
-96.3%
โ€”
Aug 11, 22
โœ“
-0.53
Est -0.73
+27.4%
1058335.0B
Est 1095818.4B
-3.4%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.